Septerna SEPN
NASDAQ SEPN
$37.71 -0.34 (-0.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Septerna (SEPN) Return on Assets [ROA] (2024 - 2026)

Updated

Septerna's Return on Assets [ROA] was -4.27% in Q2 2026, up 16.34 percentage points from -20.61% a year earlier and up 1.92 percentage points from the prior quarter.

Analysis

Septerna (SEPN) Return on Assets [ROA] (2024 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Septerna came in at -9.29%, up 15.16 percentage points from FY2024.

  • In earlier years, Return on Assets [ROA] was -24.44% in FY2024.
  • Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters.
  • Per Business Quant data, SEPN's Return on Assets [ROA] in the three quarters before Q2 2026 was -6.18% (Q1 2026), -8.13% (Q4 2025) and -11.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Septerna 1.72 Bn 1.72 Bn - -4.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.27%
Mar 31, 2026 -6.18%
Dec 31, 2025 -8.13%
Sep 30, 2025 -11.51%
Jun 30, 2025 -20.61%
Mar 31, 2025 -17.81%
Dec 31, 2024 -22.89%
API Access

Septerna Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SEPN&period=max&api_key=YOUR_API_KEY